Loading MindReaderBio...
Target >90% Returns
Smarter Biotech,
Better Market Decisions
PhD/MD Science + Investor Acumen
Biotech investing requires a complete 360° view. We bridge the gap between science and finance.
Scientific Excellence
PhD/MD-Level Analysis
- Deep dive into MOA
- Trial design evaluation
- Statistical rigor check
- Competitive landscape
Investor Expertise
Proven Financial Success
- >90% portfolio returns
- Risk-adjusted sizing
- Entry/exit strategies
Who This Is For
We are not for everyone. We build high-conviction portfolios for serious investors.
Ideal for Investors Who:
- Have experience investing but want biotech-specific expertise
- Understand that biotech is high-risk, high-reward
- Want to understand the SCIENCE behind the stocks
- Seek an edge beyond what CNBC or Bloomberg provides
- Value independent research (no Wall Street conflicts)
- Are willing to hold positions through volatility
NOT Suitable For:
- Day traders seeking quick flips
- Risk-averse investors (biotech is inherently volatile)
- Those expecting guaranteed returns
- Investors unwilling to do additional due diligence
- People looking for 'hot tips' without understanding the thesis
- Short-term thinking (weeks/months)
Performance Metrics
Results that
Outperform the Market.
>90%
Portfolio
Our 2025 portfolio returns significantly outperformed the XBI biotech index.
Win Rate
72%
Profitable Trades
Benchmark (XBI)
15%
Estimated Market Avg
Total Transparency Commitment
We publish every recommendation, entry price, and exit in real-time. No hiding behind vague "watchlists".